Loading...
Market
Will the Alzheimer's blood test be integrated into clinical practice in Australia by mid-2026?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Reports from Australian healthcare institutions or government health departments
Story
Melbourne Researchers Develop Cost-Effective Blood Test to Detect Alzheimer’s Disease for Those Over Age 65
Oct 28, 2024, 01:01 PM
Recent advancements in blood-based biomarkers have shown promise in detecting Alzheimer's disease before symptoms manifest, presenting both clinical and ethical challenges. Researchers at The Florey Institute in Melbourne have developed a simple and cost-effective blood test that can identify Alzheimer's more quickly and accurately. This breakthrough raises important questions about the next steps following a positive result for amyloid plaques and tau tangles. Additionally, researchers in the U.K. and Germany are optimistic about their findings related to Huntington’s disease, which could facilitate early detection and treatment. These developments highlight the growing importance of blood tests for Alzheimer's, particularly for individuals over the age of 65, as the medical community prepares to integrate these tools into clinical practice.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
0-5 • 25%
6-10 • 25%
11-15 • 25%
16 or more • 25%
Yes • 50%
No • 50%
0-10 • 25%
11-20 • 25%
21-30 • 25%
31 or more • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Less than 10,000 • 25%
10,000 to 50,000 • 25%
50,001 to 100,000 • 25%
More than 100,000 • 25%
Widely adopted (>75% of clinics) • 25%
Moderately adopted (50-75% of clinics) • 25%
Sparsely adopted (25-50% of clinics) • 25%
Rarely adopted (<25% of clinics) • 25%
Less than 20% • 25%
20%-40% • 25%
40%-60% • 25%
More than 60% • 25%